Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells

NCT04224207 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa
Inherited Retinal Dystrophy

Interventions

BIOLOGICAL: Wharton's jelly derived mesenchymal stem cell

Sponsor

Ankara Universitesi Teknokent